Monica Chelius, MD

University of Pennsylvania
Philadelphia, PA

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 3347 - The Impact of Standard vs. Hypofractionated Total Skin Electron Beam Therapy (TSE) on Cytopenias in Mycosis Fungoides/Sezary Syndrome (MF/SS)

  Tuesday, October 1, 2024
  4:00 PM – 5:00 PM ET

• 3348 - Radiation in Combination with Bispecific Therapy Does Not Suggest Excess Toxicity in B-Cell Lymphomas

  Tuesday, October 1, 2024
  4:00 PM – 5:00 PM ET

• 1119 - Normalization of Lactate Dehydrogenase (LDH) as a Potential Prognostic Factor for Relapsed/Refractory Aggressive B-Cell Lymphoma (R/R BCL) Patients Receiving CAR T Following Bridging Radiotherapy: Res

  Wednesday, October 2, 2024
  8:05 AM – 8:10 AM ET